5013-77-4 Usage
Description
(2,4-Dichlorobenzyl)methylamine is an organic compound characterized by its molecular structure that features a benzyl group with two chlorine atoms at the 2nd and 4th positions, attached to a methylamine group. This chemical structure endows it with specific reactivity and properties that make it suitable for various applications in the chemical and pharmaceutical industries.
Uses
Used in Pharmaceutical Industry:
(2,4-Dichlorobenzyl)methylamine is used as a precursor in the synthesis of 1-benzyloxypyrazin-2(1H)-one derivatives. These derivatives are known for their potential pharmaceutical applications, including the development of new drugs with various therapeutic effects. (2,4-Dichlorobenzyl)methylamine's reactivity and structural features allow for the creation of a diverse range of pyrazinone-based molecules with different biological activities.
Used in Chemical Synthesis:
In the chemical industry, (2,4-Dichlorobenzyl)methylamine serves as an intermediate in the synthesis of various organic compounds. Its unique structure allows for further functionalization and modification, leading to the production of a wide array of specialty chemicals with specific applications in areas such as materials science, agrochemicals, and dyes.
Check Digit Verification of cas no
The CAS Registry Mumber 5013-77-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,1 and 3 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5013-77:
(6*5)+(5*0)+(4*1)+(3*3)+(2*7)+(1*7)=64
64 % 10 = 4
So 5013-77-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H9Cl2N/c1-11-5-6-2-3-7(9)4-8(6)10/h2-4,11H,5H2,1H3/p+1
5013-77-4Relevant articles and documents
AZETIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF METABOLIC AND INFLAMMATORY DISEASES
-
Page/Page column 93, (2012/08/07)
Compounds are disclosed that have a formula represented by the following: These compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example inflammatory conditions, infectious diseases, autoimmune diseases, diseases involving impairment of immune cell functions, cardiometabolic diseases, and/or proliferative diseases.
Benzylamines: Synthesis and evaluation of antimycobacterial properties
Meindl,Von Angerer,Schonenberger,Ruckdeschel
, p. 1111 - 1118 (2007/10/02)
The synthesis of benzylamines with various N-alkyl chains and substituents in the aromatic system as well as their evaluation on Mycobacterium tuberculosis H 37 Ra are described. The most active compounds in this test, N-methyl-3-chlorobenzylamine (MIC 10.2 μg/mL), N-methyl-3,5-dichlorobenzylamine (93, MIC 10.2 μg/mL), and N-butyl-3,5-difluorobenzylamine (MIC 6.4 μg/mL), also exhibited a marked inhibitory effect on Mycobacterium marinum and Mycobacterium lufu used for the determination of antileprotic properties. The combination of 93 with aminosalicylic acid, streptomycin, or dapsone exert marked supra-additive effects on M. tuberculosis H 37 Ra.